Filing Details
SCYNEXIS INC (NASDAQ:SCYX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:SCYX
SCYNEXIS INC (SCYX) Files Quarterly Report for Q0
SCYNEXIS INC (NASDAQ:SCYX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
At publication ·
What changed
SCYNEXIS INC (NASDAQ:SCYX) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- SCYNEXIS INC filed its quarterly 10-Q report with the SEC on November 05, 2026.
- The healthcare company's stock trades at $3.84 per share with a market capitalization of $27.3M.
- Q0 revenue figure was not disclosed in this filing summary.
Market Context
SCYNEXIS INC's stock currently trades at $3.84 with a market capitalization of $27.3M.
The 10-Q provides SCYNEXIS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for SCYNEXIS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SCYX Stock Page
Frequently Asked Questions
Where can I read SCYX's SEC filings?
Browse all filings on our SCYX SEC filings page.
What types of SEC filings does SCYNEXIS INC file?
Public companies like SCYNEXIS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.